The Cancer Letter

Inside information on cancer research and drug development

In Brief

Paula Fracasso named deputy director at Massey Cancer Center, president of cancer service line at VCU Health

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Paula M. Fracasso was named deputy director of Massey Cancer Center and senior vice president of the cancer service line at VCU Health.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

VCU Massey scientists pinpoint druggable target in TNBC

Through a genomic screening method known as CRISPR/CAS9 screening, Massey scientists—led by Anthony Faber and Jennifer Koblinski—identified a specific enzyme called UBA1 that revealed itself as an ideal therapeutic target in triple negative breast cancer. Using a novel UBA-inhibiting drug called TAK-243, they blocked the cellular function of UBA1 and effectively killed cancer cells in patient-derived breast tumors in mice.
In Brief

Miami Cancer Institute, ChristianaCare, Ochsner, OSUCCC – James, Massey named ACCC 2022 Innovator Award winners

The Association of Community Cancer Centers named the winning programs for its 12th annual ACCC Innovator Awards, highlighting the year’s solutions to improving cancer care delivery and the patient experience. The five ACCC Innovator Award winners feature programs in areas such as remote patient monitoring, improving oral oncolytic compliance, and addressing social determinants of health. 
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account